The Use of Mechanistic DM-PK-PD Modeling to Assess the Power of Pharmacogenetic Studies—CYP2C9 and Warfarin as an Example

Author(s): Gemma Dickinson, Martin Lennard, Geoffrey Tucker, Amin Rostami-Hodjegan
Year: July 1, 2007
Learn More LinkedIn Twitter Facebook Email